Threes a charm in a triple-drug combination for transplant p
Discovered nearly 45 years ago in the volcanic soils of fabled Easter Island in the Pacific, a drug first thought of as an antifungal agent has found a new purpose by boosting the survival of leukemia patients after blood stem cell transplants.

In a clinical trial conducted by Fred Hutchinson Cancer Research Center, the addition of a third drug, sirolimus, to a standard two-drug regimen effectively cut in half the incidence of acute graft-vs.-host disease, or GVHD, a common and dangerous complication of these lifesaving procedures....

http://www.fredhutch.org/en/news/center-news/2016/12/threes-a-charm-in-triple-drug-combination-for-transplant-patients.html
Like
Comment
Share